68 Ga-Labeled Magnetic-NIR Persistent Luminescent Hybrid Mesoporous Nanoparticles for Multimodal Imaging-Guided Chemotherapy and Photodynamic Therapy
Rui Zou,Yifan Gao,Yong Zhang,Ju Jiao,Ka-Leung Wong,Jing Wang
DOI: https://doi.org/10.1021/acsami.0c21623
2021-02-22
Abstract:Featured with a zero-autofluorescence background, superior signal-to-noise ratio, high sensitivity, and deep penetration ability, near-infrared persistent luminescence nanoparticle (NIR-PLNP)-based multimodal nanoprobes show great potential for full-scale noninvasive cancer diagnosis. However, direct synthesis of NIR-PLNP-based multimodal nanoprobes with high drug loading capacity to meet growing cancer theranostic demands remains a challenge. In this work, multifunctional hybrid mesoporous nanoparticles (HMNPs) that integrate NIR-PLNPs (Ga<sub>2</sub>O<sub>3</sub>:Cr<sup>3+</sup>, Nd<sup>3+</sup>), magnetic nanoparticles (Gd<sub>2</sub>O<sub>3</sub>), and radionuclides (<sup>68</sup>Ga) are designed and constructed via a large-pore (mesoporous silica nanoparticle) MSN-templated strategy. The ingenious composition design endows HMNPs with rechargeable NIR-PL, superior longitudinal relaxivity, and excellent radioactivity, making these versatile nanoparticles available for long-term <i>in vivo</i> NIR-PL imaging, magnetic resonance imaging (MRI), and positron emission tomography (PET) imaging. More importantly, the application of large-pore MSN templates maintains the mesoporous structure of HMNPs, promising excellent drug loading capacity of these nanoparticles. As a proof-of-concept, HMNPs loaded with a high dose of DOX (chemotherapy agent) and Si-Pc (photosensitizer) are rationally designed for chemotherapy and NIR-PL-sensitized photodynamic therapy (PDT), respectively. Studies with mice tumor models demonstrate that the DOX/Si-Pc-loaded HMNPs possess excellent cancer cell killing ability and an outstanding tumor suppression effect without systemic toxicity. This work shows the great potential of HMNPs as an "all-in-one" nanotheranostic tool for multimodal NIR-PL/MR/PET imaging-guided chemotherapy and NIR-PL-sensitized photodynamic cancer therapy and provides an innovative paradigm for the development of NIR-PLNP-based nanoplatforms in cancer theranostic.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c21623?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c21623</a>.Size distributions and BET analysis (Figure S1), EDS spectrum (Figure S2), the dynamic light scattering (DLS) analysis (Figure S3), stability study (Figure S4), T<sub>1</sub>-weighted MRI and the corresponding longitudinal relaxivity (Figure S5), time-dependent signal-to-noise ratios (SNR) (Figure S6), filter-paper chromatograms (Figure S7), time-dependent tumor uptake (Figure S8), biodistribution (Figure S9), persistent luminescence images (Figure S10), pathologic analysis (Figure S11), UV–vis absorbance spectra and the corresponding standard curve of DOX (Figure S12), blood hemolysis analysis (Figure S13), photographs of Si-Pc-HMNP solution (Figure S14), UV–vis absorbance spectra and the corresponding standard curve of Si-Pc (Figure S15), fluorescent emission spectrum (Figure S16), singlet oxygen detection (Figure S17), and confocal images (Figure S18) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c21623/suppl_file/am0c21623_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
materials science, multidisciplinary,nanoscience & nanotechnology